Evidence map›Paper›PMID 41120558›Full record

ArticleScientific reports2025

Representation learning enables robust single cell phenotyping in whole slide liquid biopsy imaging.

Amin Naghdloo, Dean Tessone, Rajiv M Nagaraju, Brian Zhang, Jeffrey Kang, Shouyi Li, Assad Oberai, James B Hicks, Peter Kuhn

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Amin Naghdloo *Convergent Science Institute in Cancer, University of Southern California, Los Angeles, CA, 90089, USA.
Dean Tessone *Convergent Science Institute in Cancer, University of Southern California, Los Angeles, CA, 90089, USA.
Rajiv M Nagaraju *Convergent Science Institute in Cancer, University of Southern California, Los Angeles, CA, 90089, USA.
Brian ZhangConvergent Science Institute in Cancer, University of Southern California, Los Angeles, CA, 90089, USA.
Jeffrey KangConvergent Science Institute in Cancer, University of Southern California, Los Angeles, CA, 90089, USA.
Shouyi LiConvergent Science Institute in Cancer, University of Southern California, Los Angeles, CA, 90089, USA.
Assad OberaiConvergent Science Institute in Cancer, University of Southern California, Los Angeles, CA, 90089, USA.
James B HicksConvergent Science Institute in Cancer, University of Southern California, Los Angeles, CA, 90089, USA. jameshic@usc.edu.
Peter KuhnConvergent Science Institute in Cancer, University of Southern California, Los Angeles, CA, 90089, USA. kuhn42@usc.edu.

Funding

USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fumito Ito · 1985 to 2026
$181.4M
Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple MyelomaU01CA285013 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KUHN, PETER · 2023 to 2025
$3.4M
Device for Preservation of Cell Free RNA in SalivaR21CA258013 · NCI · PRIME GENOMICS, INC. · PI NAUTIYAL, SHIVANI · 2021 to 2022
$460k
Breast Cancer Research Foundation BCRF-24-089Congressionally Directed Medical Research Programs CA220785Dr. Miriam and Sheldon G. Adelson Medical Research Foundation 013694NCI NIH HHS P30 CA014089NCI NIH HHS R21 CA258013NCI NIH HHS U01CA258013NCI NIH HHS U01 CA285013Schlegel Family Endowed Fellowship Kuhn LabUSC Michelson Center Convergent Science Institute in Cancer Kuhn LabVassiliadis Research Fund Kuhn LabWinnie and James Hart Endowed Fell Kuhn Lab
6 · The paper itself

Abstract

Tumor-associated cells in liquid biopsy are promising biomarkers for cancer detection, diagnosis, prognosis, and monitoring. Yet, their rarity, heterogeneity, and plasticity pose challenges for accurate identification and characterization. Enrichment-free whole slide imaging of all circulating cells offers a comprehensive, unbiased approach to capture this phenotypic diversity. However, current analysis methods often rely on engineered features and manual expert review, making them prone to technical variability and subjective bias. To address this, we present a deep contrastive learning framework for feature extraction from whole slide immunofluorescence microscopy images, enabling robust identification and stratification of single circulating cells. Our learned features achieve 92.64% accuracy in classifying diverse cell phenotypes and improve downstream tasks such as outlier detection and clustering. Additionally, our model enables automated identification and enumeration of rare phenotypes, reaching an average F1-score of 0.93 on contrived samples mimicking circulating tumor and endothelial cells, and 0.858 across circulating tumor cell phenotypes in clinical samples. This workflow provides a scalable, reproducible solution for analyzing tumor-associated cellular biomarkers, with strong potential to enhance clinical prognosis and guide personalized treatment strategies.

Indexed as

Image Processing, Computer-AssistedNeoplasmsNeoplastic Cells, CirculatingSingle-Cell AnalysisBiomarkers, TumorDeep LearningHumansLiquid BiopsyMicroscopy, FluorescencePhenotypeBiomarkers, TumorContrastive learningImmunofluorescence microscopyLiquid biopsySingle-cell phenotypingWhole slide imaging

Identifiers

PMID41120558
PMCPMC12540859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.